Chloe Orkin, Barts Health NHS Trust and Athena Swan Chair QMUL School of Medicine
Barts Health NHS Trust and Athena Swan Chair QMUL School of MedicineChloe Orkin is a Professor of HIV Medicine at Queen Mary University of London and Consultant Physician at the Royal London Hospital. She is Chair of the British HIV Association and Vice President of the Medical Women's Federation (UK). She runs a busy HIV & HIV/ HCV clinical trials unit. Her specialist interests are: antiretroviral therapy and blood-borne virus testing.
Presenter Of 1 Presentation
Oral abstract session
OAB0302 - Analysis of protocol defined virologic failure through week 48 from a phase 2 trial (P011) of islatravir and doravirine in treatment-naïve adults with HIV-1 infection
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Analysis of protocol defined virologic failure through week 48 from a phase 2 trial (P011) of islatravir and doravirine in treatment-naïve adults with HIV-1 infection
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 3 Presentations
Major industry sponsor satellite
Challenging Case 2: A Patient Who May Benefit From Treatment Simplification
Room
Satellite Channel 1
Major industry sponsor satellite
Question and Answer
Speaker
Room
Satellite Channel 1
Oral abstract session
Analysis of protocol defined virologic failure through week 48 from a phase 2 trial (P011) of islatravir and doravirine in treatment-naïve adults with HIV-1 infection
Session Name
Room
Abstract Sessions On-Demand Channel
Moderator Of 1 Session
Major industry sponsor satellite
Room
Satellite Channel 1
Session Description
Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of HIV treatment. Clinicians must keep apprised of new data on treatment strategies, including drug simplification and long-acting injectables, selection of appropriate individualized therapy, and effective management of treatment side effects. In this interactive, case-based program, expert faculty will provide guidance on how to incorporate new treatment strategies into clinical practice. They will also discuss various aspects of HIV management, including the selection of an initial antiretroviral regimen for a patient with advanced disease; treatment modification in women; and treatment simplification.